Louise Massara

Name:	Louise Massara
Affiliation:	University of Cambridge
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	14 Jan 2025, 5:11 p.m.

Public lists managed by Louise Massara

• Clinical Neurosciences Seminars

Talks given by Louise Massara

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

• “Complement in Alzheimer’s Disease”
• “Ambient Mass Spectrometry in Neuroscience: From spatial biology to neurosurgery”
• "The Importance of Behavioural Bioassays in Neuroscience"
• “Are Toll-like receptors and inflammasomes therapeutic targets for neuroinflammation?”
• “Molecular and genetic mechanisms of neuron-glia interactions”
• "Autophagy and neurodegeneration"
• "Leveraging transcriptomic maps to navigate human brain diseases"
• "Neuronal and glial responses to the absence of microglia"
• "White matter in dementia; from lesions to plasticity"
• “Axoptosis: Mechanisms for coordinating axonal degeneration”
• “In vivo assessment of synaptic loss in non-AD tauopathies”
• “Inducing mtDNA alterations in mouse dopaminergic neurons to study if and how they contribute to Parkinsons disease like phenotype”
• “Sickness behaviour and depression: an updated model of peripheral central immune interactions”
• "The prohibitin proteins in myelination"
• "HUNTINGTON’S DISEASE- Where has our research taken us to date?"
• “Can we block axon degeneration in disease?”
• “Myelinated axon formation, health and function”
• “Myelin's highway to the axon and implications for axonal support”
• “Functional transcriptomics in neurodegenerative disorders”
• “Beyond proteinopathies, in vivo clinical markers for inflammation and synaptic loss in frontotemporal lobar degeneration”
• Structure-function of the Endoplasmic Reticulum and neuronal de/regeneration
• “Presynaptic dysfunction in neurodevelopmental disorders”
• “Targeting astrocytes to protect the brain in Vascular Cognitive Impairment”
• "Fumarate hydratase and cancer: a paradigm of oncometabolism”
• "Targeting axon transport to support axon regeneration in the adult CNS”
• "Can we improve human nerve regeneration?”
• “Distinctive gene expression distribution in microglia and astrocytes in relation to distance from plaques in NLF knockin mice, where differences are undetectable in bulk RNAseq.”
• "Prion diseases: risk factors, experimental treatments, and ways to improve care"
• "What did organoids do for us? - mechanistic & therapeutic discoveries at single cell resolution in ALS/FTD”
• The Interplay between Local Protein Synthesis and Axon/NMJ Maintenance and Degeneration in ALS
• Passive brain tumour visualisation during surgery using computer vision
• "Altered synaptic ingestion by human microglia in Alzheimer's disease"
• “Biology in balance: human diploid genome integrity, gene dosage & genomic medicine”
• “Facing the impact of dementia globally with a focus on translational studies to reduce risk”
• “B cell diversity in neuroinflammation”
• "Pathogenesis and Prevention of Retinal Detachment"
• “Glucose, Diabetes and the Brain"
• “Truncated tau as a model of human tauopathy”
• Molecular traits of cell type-specific reactivity in neuroinflammation
• Genomically Humanised Mouse Models For ALS Research
• From mechanisms to treatment, in disorders of frontotemporal lobar degeneration
• The suprachiasmatic body clock: circadian genes, cells and circuits
• “Chemical genetic approaches for elucidating PARP function in cells”
• Title to be confirmed
• Immune/inflammatory mechanisms in stroke
• Mechanisms of distal axon degeneration and neuroprotection in peripheral neuropathies
• Imaging the locus coeruleus in Parkinsonian disorders
• Perineuronal net (PNN): an exoskeleton for neurons
• Directed Evolution of Adeno-associated Viral Variants Optimized for Clinical Gene Therapy
• Directed Evolution of Adeno-associated Viral Variants Optimized for Clinical Gene Therapy
• Human pain channelopathies
• “Autoantibodies, receptors and ion channels in stiff person syndromes”
• fMRI across the lifespan: is it good enough to be BOLD?
• The impact of systemic inflammation on the vulnerable brain: at the interface of dementia and delirium
• Physiological, humanised mouse models for neurodegenerative disease
• Chromatin remodelling determines cell-type specific Notch activity in the developing mouse brain

Talks organised by Louise Massara

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Louise Massara actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• “Psychedelics: how do they work?”
• “Compartmentalized intrathecal inflammation in multiple sclerosis as driver of disease progression: from neuropathology to clinical correlates”
• “A novel role at organelle contacts for protrudin, a protein that promotes axonal regeneration”
• “Leveraging transcriptomics to understand neurodegeneration”
• “Rincell-1: first-in-human, pluripotent stem cell-based therapy for hearing loss”
• “Herpes and dementia: the enemy within”
• “Protecting and regenerating the diseased nervous system: Lessons from development”
• “On Brains and Vessels: How perivascular fibroblasts contribute to ALS neurodegeneration”
• “Translational applications of human brain charts: from clinical to population neuroscience”
• “Tools for studying variation in the dark genome”
• “The all ‘A’s: ageing, Alzheimer, autophagy, AI, and an ‘A’ compound in brain health and longevity”
• “Atomic pathology of neurodegenerative diseases by cryo-EM of amyloid filaments”
• “Biomarkers for Alzheimer’s disease in clinical routine - a pretty Swedish perspective”
• “Enhancing Insight into Neurodegenerative Disease-Associated Genes via Long-Read RNA-Sequencing”
• “Complement in Alzheimer’s Disease”
• “Ambient Mass Spectrometry in Neuroscience: From spatial biology to neurosurgery”
• "The Importance of Behavioural Bioassays in Neuroscience"
• “Are Toll-like receptors and inflammasomes therapeutic targets for neuroinflammation?”
• “Translational applications of human brain charts: from clinical to population neuroscience”
• “Unexpected physiologic role of alpha-synuclein Serine-129 phosphorylation”
• “Thoughts on the interaction of different memory systems: evidence from semantic dementia”
• “Energy Matters: Programming axonal mitochondrial maintenance and bioenergetics to power neural regeneration”
• “Energy Matters: Programming axonal mitochondrial maintenance and bioenergetics to power neural regeneration”
• “Molecular and genetic mechanisms of neuron-glia interactions”
• "Autophagy and neurodegeneration"
• "Leveraging transcriptomic maps to navigate human brain diseases"
• "Neuronal and glial responses to the absence of microglia"
• "White matter in dementia; from lesions to plasticity"
• “Gene Therapy and beyond – hopes and challenges in therapy development for neurological disorders”
• “Axoptosis: Mechanisms for coordinating axonal degeneration”
• “In vivo assessment of synaptic loss in non-AD tauopathies”
• “Inducing mtDNA alterations in mouse dopaminergic neurons to study if and how they contribute to Parkinsons disease like phenotype”
• “Sickness behaviour and depression: an updated model of peripheral central immune interactions”
• "The prohibitin proteins in myelination"
• "HUNTINGTON’S DISEASE- Where has our research taken us to date?"
• “Can we block axon degeneration in disease?”
• “Myelinated axon formation, health and function”
• “Myelin's highway to the axon and implications for axonal support”
• “Functional transcriptomics in neurodegenerative disorders”
• “Beyond proteinopathies, in vivo clinical markers for inflammation and synaptic loss in frontotemporal lobar degeneration”
• Structure-function of the Endoplasmic Reticulum and neuronal de/regeneration
• “Presynaptic dysfunction in neurodevelopmental disorders”
• “Targeting astrocytes to protect the brain in Vascular Cognitive Impairment”
• "Fumarate hydratase and cancer: a paradigm of oncometabolism”
• "Targeting axon transport to support axon regeneration in the adult CNS”
• "Can we improve human nerve regeneration?”
• “Distinctive gene expression distribution in microglia and astrocytes in relation to distance from plaques in NLF knockin mice, where differences are undetectable in bulk RNAseq.”
• "Prion diseases: risk factors, experimental treatments, and ways to improve care"
• "What did organoids do for us? - mechanistic & therapeutic discoveries at single cell resolution in ALS/FTD”
• The Interplay between Local Protein Synthesis and Axon/NMJ Maintenance and Degeneration in ALS
• Passive brain tumour visualisation during surgery using computer vision
• "Altered synaptic ingestion by human microglia in Alzheimer's disease"
• “Biology in balance: human diploid genome integrity, gene dosage & genomic medicine”
• “Facing the impact of dementia globally with a focus on translational studies to reduce risk”
• “B cell diversity in neuroinflammation”
• "Pathogenesis and Prevention of Retinal Detachment"
• “Glucose, Diabetes and the Brain"
• “Truncated tau as a model of human tauopathy”
• Molecular traits of cell type-specific reactivity in neuroinflammation
• Genomically Humanised Mouse Models For ALS Research
• From mechanisms to treatment, in disorders of frontotemporal lobar degeneration
• The suprachiasmatic body clock: circadian genes, cells and circuits
• “Chemical genetic approaches for elucidating PARP function in cells”
• Title to be confirmed
• Immune/inflammatory mechanisms in stroke
• Mechanisms of distal axon degeneration and neuroprotection in peripheral neuropathies
• Imaging the locus coeruleus in Parkinsonian disorders
• Perineuronal net (PNN): an exoskeleton for neurons
• Directed Evolution of Adeno-associated Viral Variants Optimized for Clinical Gene Therapy
• Directed Evolution of Adeno-associated Viral Variants Optimized for Clinical Gene Therapy
• Human pain channelopathies
• “Autoantibodies, receptors and ion channels in stiff person syndromes”
• fMRI across the lifespan: is it good enough to be BOLD?
• The impact of systemic inflammation on the vulnerable brain: at the interface of dementia and delirium
• Physiological, humanised mouse models for neurodegenerative disease
• Chromatin remodelling determines cell-type specific Notch activity in the developing mouse brain
• Genetic modifiers in Huntington’s disease: an expanding tale